/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE
SERVICES OR DISSEMINATION IN THE UNITED
STATES/
Aleafia (TSXV: ALEF) and CannTrust (TSX: TRST)
form cultivation and patient relationship.
TORONTO, May 1, 2018 /CNW/ - Aleafia Health Inc.
(TSXV: ALEF; OTC: CAMDF) ("Aleafia") or (the
"Company"), is pleased to announce a formalized relationship
with CannTrust Inc. (TSX: TRST) ("CannTrust"), which both
companies feel will be of significant mutual benefit. The companies
have entered into a strategic genetic supply agreement through
which Aleafia will receive various strains of high-quality starter
genetics for its first licensed production facility in Scugog,
Ontario, and CannTrust taking the
right of first refusal to purchase product from Aleafia.
CannTrust has provided starter genetics to Aleafia for
cultivation, which is underway at the Aleafia Farms licensed
facility. Aleafia is expecting to complete its first harvest in May
and, once completed, Aleafia is expecting to receive its ACMPR
sales and distribution license shortly thereafter, subject to a
successful inspection by Health Canada.
CannTrust will also have the ability to purchase product from
Aleafia's harvest. This would support CannTrust's patient base and
provide Aleafia with revenue growth in the near term, augmenting
the existing revenue derived from the nationwide Canabo clinic
network.
Aleafia chose to work with CannTrust because of CannTrust's
demonstrably high-quality production standards and quality
genetics. As part of the agreement, Aleafia will also
refer a significant percentage of its growing
patient base to CannTrust, in cases where patients
require strains that Aleafia may not initially be able to
supply out of the current facility. Notably, Aleafia has begun
an expansion strategy to increase cultivation capacity from its
current abilities. The initial-phase expansion of 150,000
square feet is fully
funded with plans for future expansion on its
76-acre property in Scugog, Ontario.
"The entire Aleafia team is pleased with this exciting
opportunity to work with CannTrust," said Executive Director
Julian Fantino. "Standardized
repeatable product for our patients is something we feel strongly
about at Aleafia and is a critical part of meeting the exacting
standards required by our expanding network of more than 30,000
patients. CannTrust already does this very well, which made the
decision to work together an easy one. We thank CannTrust for its
continued support and look forward to working closely together in
the future."
"This relationship is strategic for us as the Aleafia model is
complementary to ours on many levels," said CannTrust President
Brad Rogers. "Aleafia's ability to
meet our rigorous production-quality standards and deliver
high-quality product is key, along with CannTrust being the
preferred partner in Aleafia's clinic business. This relationship
is a real win-win for both organizations."
About Aleafia Health Inc.:
Aleafia Health Inc. is one of Canada's leading,
vertically integrated medical cannabis companies with a unique
patient-focused, medical cannabis healthcare solution. Led by a
distinguished and experienced corporate leadership
team, Aleafia Health Inc. is pioneering a patient-centric
experience that includes personalized services before, during
and after treatment. Aleafia's 22 cannabis clinics are staffed
by licensed, practicing physicians. Aleafia Health Inc.
has realized sustained patient acquisition growth and retention,
underscoring the success of Canada's first
"patient-centric" cannabis-based health network. For more
information, please visit www.aleafiainc.com.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
This press release contains forward-looking statements and
information that are based on the beliefs of management and reflect
the Aleafia's current expectations. When used in this press
release, the words "estimate", "project", "belief", "anticipate",
"intend", "expect", "plan", "predict", "may" or "should" and the
negative of these words or such variations thereon or comparable
terminology are intended to identify forward-looking statements and
information. The forward-looking statements and information in
this press release includes information relating to the
implementation of Aleafia Health's business plan. Such
statements and information reflect the current view of Aleafia with
respect to risks and uncertainties that may cause actual results to
differ materially from those contemplated in those forward-looking
statements and information.
Although Aleafia believes that the assumptions and factors used
in preparing, and the expectations contained in, the
forward-looking information and statements are reasonable, undue
reliance should not be placed on such information and statements,
and no assurance or guarantee can be given that such
forward-looking information and statements will prove to be
accurate, as actual results and future events could differ
materially from those anticipated in such information and
statements. Accordingly, readers should not place undue
reliance on any forward-looking information or statements contained
in this press release. The forward-looking information contained in
this press release is made as of the date hereof, and Aleafia does
not undertake to update any forward-looking information that is
contained or referenced herein, whether as a result of new
information, future events or otherwise, except in accordance with
applicable securities laws. All subsequent written and oral
forward-looking information and statements attributable to Aleafia
or persons acting on its behalf is expressly qualified in its
entirety by this notice.
SOURCE Aleafia Inc.